What's breaking now, across thousands of outlets.
AbbVie has agreed to a discovery and commercialization deal with Brise Pharma for two preclinical migraine programs. The Beijing-based partner said Monday the agreement actually stemmed from 2024. An investor relations ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
INTO, TUI and ASTI direct members not to co-operate with any new model until concerns addressed in letter
The Abia State Government has designated the Specialist Hospital and Diagnostic Centre, Amachara, as an isolation centre for Ebola, pending the completion of the Infectious Disease Hospital in Aba.
Business leaders in Jalisco are at odds over the impacts of the Guadalajara water crisis on investment, while a new designation of origin seal could boost boost visibility for the state's most iconic…
Pregnant patients receiving medication to treat opioid use disorder should not reduce their medication dose out of fear that it will worsen withdrawal symptoms in their newborns, according to a new…
FBI investigation into Thomas Markle Sr. faces potential legal complications
